Reaction
Menometrorrhagia reporting signals
As of the last recalculation, Menometrorrhagia appears in 1,815 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL (PRR 157.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Etonogestrel | 482 | 157.3 | 158.9 |
| Levonorgestrel | 409 | 29.8 | 29.8 |
| Etonogestrel And Ethinyl Estradiol | 48 | 25.5 | 25.5 |
| Drospirenone And Ethinyl Estradiol | 69 | 18.6 | 18.6 |
| Ketoprofen | 15 | 13.2 | 13.2 |
| Copper | 46 | 12.5 | 12.5 |
| Medroxyprogesterone Acetate | 45 | 10.6 | 10.6 |
| Rivaroxaban | 102 | 5.9 | 5.9 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 3 | 4.0 | 4.0 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 7 | 3.4 | 3.4 |